Targeting Class I Histone Deacetylases in a "Complex" Environment.
Sign Up to like & getrecommendations! Published in 2017 at "Trends in pharmacological sciences"
DOI: 10.1016/j.tips.2016.12.006
Abstract: Histone deacetylase (HDAC) inhibitors are proven anticancer therapeutics and have potential in the treatment of many other diseases including HIV infection, Alzheimer's disease, and Friedreich's ataxia. A problem with the currently available HDAC inhibitors is… read more here.
Keywords: deacetylases complex; class histone; complex environment; histone deacetylases ... See more keywords